Pharmacoeconomics of oral antibiotics: augmented proceedings of the Cefixime Round-Table Discussion held in New Orleans, October 22, 1993
Gespeichert in:
| Format: | Tagungsbericht Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Auckland [u.a.]
Adis Internat.
1994
|
| Schriftenreihe: | PharmacoEconomics
5, Suppl. 2 |
| Schlagworte: | |
| Beschreibung: | Einzelaufnahme eines Zeitschr.-Suppl. |
| Beschreibung: | 43 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV010545462 | ||
| 003 | DE-604 | ||
| 005 | 20041006 | ||
| 007 | t | ||
| 008 | 960103s1994 d||| |||| 10||| engod | ||
| 035 | |a (OCoLC)34533872 | ||
| 035 | |a (DE-599)BVBBV010545462 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-19 | ||
| 245 | 1 | 0 | |a Pharmacoeconomics of oral antibiotics |b augmented proceedings of the Cefixime Round-Table Discussion held in New Orleans, October 22, 1993 |c guest ed. P. G. Davey ... |
| 264 | 1 | |a Auckland [u.a.] |b Adis Internat. |c 1994 | |
| 300 | |a 43 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a PharmacoEconomics |v 5, Suppl. 2 | |
| 500 | |a Einzelaufnahme eines Zeitschr.-Suppl. | ||
| 650 | 4 | |a Antibiotics |v Congresses | |
| 650 | 4 | |a Antibiotics |x Cost effectiveness | |
| 650 | 4 | |a Antibiotics |x Economic aspects | |
| 650 | 0 | 7 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cephalosporine |0 (DE-588)4139403-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cefixim |0 (DE-588)4204565-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Orale Applikation |0 (DE-588)4202348-8 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1993 |z New Orleans La. |2 gnd-content | |
| 689 | 0 | 0 | |a Cephalosporine |0 (DE-588)4139403-3 |D s |
| 689 | 0 | 1 | |a Orale Applikation |0 (DE-588)4202348-8 |D s |
| 689 | 0 | 2 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Cefixim |0 (DE-588)4204565-4 |D s |
| 689 | 1 | 1 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Davey, Peter G. |e Sonstige |4 oth | |
| 711 | 2 | |a Cefixime Round Table Discussion |d 1993 |c New Orleans, La. |j Sonstige |0 (DE-588)16141054-6 |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007028580 | ||
Datensatz im Suchindex
| _version_ | 1804125013167570944 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV010545462 |
| ctrlnum | (OCoLC)34533872 (DE-599)BVBBV010545462 |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01798nam a2200457 cb4500</leader><controlfield tag="001">BV010545462</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20041006 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">960103s1994 d||| |||| 10||| engod</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)34533872</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010545462</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacoeconomics of oral antibiotics</subfield><subfield code="b">augmented proceedings of the Cefixime Round-Table Discussion held in New Orleans, October 22, 1993</subfield><subfield code="c">guest ed. P. G. Davey ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Auckland [u.a.]</subfield><subfield code="b">Adis Internat.</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">43 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">PharmacoEconomics</subfield><subfield code="v">5, Suppl. 2</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zeitschr.-Suppl.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibiotics</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibiotics</subfield><subfield code="x">Cost effectiveness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibiotics</subfield><subfield code="x">Economic aspects</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cephalosporine</subfield><subfield code="0">(DE-588)4139403-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cefixim</subfield><subfield code="0">(DE-588)4204565-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Orale Applikation</subfield><subfield code="0">(DE-588)4202348-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1993</subfield><subfield code="z">New Orleans La.</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Cephalosporine</subfield><subfield code="0">(DE-588)4139403-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Orale Applikation</subfield><subfield code="0">(DE-588)4202348-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Cefixim</subfield><subfield code="0">(DE-588)4204565-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Davey, Peter G.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">Cefixime Round Table Discussion</subfield><subfield code="d">1993</subfield><subfield code="c">New Orleans, La.</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)16141054-6</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007028580</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1993 New Orleans La. gnd-content |
| genre_facet | Konferenzschrift 1993 New Orleans La. |
| id | DE-604.BV010545462 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:54:48Z |
| institution | BVB |
| institution_GND | (DE-588)16141054-6 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007028580 |
| oclc_num | 34533872 |
| open_access_boolean | |
| owner | DE-12 DE-19 DE-BY-UBM |
| owner_facet | DE-12 DE-19 DE-BY-UBM |
| physical | 43 S. graph. Darst. |
| publishDate | 1994 |
| publishDateSearch | 1994 |
| publishDateSort | 1994 |
| publisher | Adis Internat. |
| record_format | marc |
| series2 | PharmacoEconomics |
| spelling | Pharmacoeconomics of oral antibiotics augmented proceedings of the Cefixime Round-Table Discussion held in New Orleans, October 22, 1993 guest ed. P. G. Davey ... Auckland [u.a.] Adis Internat. 1994 43 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier PharmacoEconomics 5, Suppl. 2 Einzelaufnahme eines Zeitschr.-Suppl. Antibiotics Congresses Antibiotics Cost effectiveness Antibiotics Economic aspects Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd rswk-swf Cephalosporine (DE-588)4139403-3 gnd rswk-swf Cefixim (DE-588)4204565-4 gnd rswk-swf Orale Applikation (DE-588)4202348-8 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1993 New Orleans La. gnd-content Cephalosporine (DE-588)4139403-3 s Orale Applikation (DE-588)4202348-8 s Kosten-Nutzen-Analyse (DE-588)4032589-1 s DE-604 Cefixim (DE-588)4204565-4 s Davey, Peter G. Sonstige oth Cefixime Round Table Discussion 1993 New Orleans, La. Sonstige (DE-588)16141054-6 oth |
| spellingShingle | Pharmacoeconomics of oral antibiotics augmented proceedings of the Cefixime Round-Table Discussion held in New Orleans, October 22, 1993 Antibiotics Congresses Antibiotics Cost effectiveness Antibiotics Economic aspects Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Cephalosporine (DE-588)4139403-3 gnd Cefixim (DE-588)4204565-4 gnd Orale Applikation (DE-588)4202348-8 gnd |
| subject_GND | (DE-588)4032589-1 (DE-588)4139403-3 (DE-588)4204565-4 (DE-588)4202348-8 (DE-588)1071861417 |
| title | Pharmacoeconomics of oral antibiotics augmented proceedings of the Cefixime Round-Table Discussion held in New Orleans, October 22, 1993 |
| title_auth | Pharmacoeconomics of oral antibiotics augmented proceedings of the Cefixime Round-Table Discussion held in New Orleans, October 22, 1993 |
| title_exact_search | Pharmacoeconomics of oral antibiotics augmented proceedings of the Cefixime Round-Table Discussion held in New Orleans, October 22, 1993 |
| title_full | Pharmacoeconomics of oral antibiotics augmented proceedings of the Cefixime Round-Table Discussion held in New Orleans, October 22, 1993 guest ed. P. G. Davey ... |
| title_fullStr | Pharmacoeconomics of oral antibiotics augmented proceedings of the Cefixime Round-Table Discussion held in New Orleans, October 22, 1993 guest ed. P. G. Davey ... |
| title_full_unstemmed | Pharmacoeconomics of oral antibiotics augmented proceedings of the Cefixime Round-Table Discussion held in New Orleans, October 22, 1993 guest ed. P. G. Davey ... |
| title_short | Pharmacoeconomics of oral antibiotics |
| title_sort | pharmacoeconomics of oral antibiotics augmented proceedings of the cefixime round table discussion held in new orleans october 22 1993 |
| title_sub | augmented proceedings of the Cefixime Round-Table Discussion held in New Orleans, October 22, 1993 |
| topic | Antibiotics Congresses Antibiotics Cost effectiveness Antibiotics Economic aspects Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Cephalosporine (DE-588)4139403-3 gnd Cefixim (DE-588)4204565-4 gnd Orale Applikation (DE-588)4202348-8 gnd |
| topic_facet | Antibiotics Congresses Antibiotics Cost effectiveness Antibiotics Economic aspects Kosten-Nutzen-Analyse Cephalosporine Cefixim Orale Applikation Konferenzschrift 1993 New Orleans La. |
| work_keys_str_mv | AT daveypeterg pharmacoeconomicsoforalantibioticsaugmentedproceedingsofthecefiximeroundtablediscussionheldinneworleansoctober221993 AT cefiximeroundtablediscussionneworleansla pharmacoeconomicsoforalantibioticsaugmentedproceedingsofthecefiximeroundtablediscussionheldinneworleansoctober221993 |